170 related articles for article (PubMed ID: 22517793)
1. Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.
Rochowski A; Olson SB; Alonzo TA; Gerbing RB; Lange BJ; Alter BP
Pediatr Blood Cancer; 2012 Nov; 59(5):922-4. PubMed ID: 22517793
[TBL] [Abstract][Full Text] [Related]
2. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic findings in a Fanconi anemia patient with AML.
Ferti A; Panani A; Dervenoulas J; Raptis SA
Cancer Genet Cytogenet; 1996 Sep; 90(2):182-3. PubMed ID: 8830732
[No Abstract] [Full Text] [Related]
4. Chromosome abnormalities in bone marrow of Fanconi anemia patients.
Berger R; Le Coniat M; Schaison G
Cancer Genet Cytogenet; 1993 Jan; 65(1):47-50. PubMed ID: 8431915
[TBL] [Abstract][Full Text] [Related]
5. How I treat MDS and AML in Fanconi anemia.
Peffault de Latour R; Soulier J
Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
[TBL] [Abstract][Full Text] [Related]
6. Two different karyotypes with 1q abnormalities in a patient with Fanconi anemia.
Oliveira NI; Ribeiro EM; Raimondi SC; Bittencourt MA; Pasquini R; Cavalli IJ
Leuk Res; 2002 Nov; 26(11):1047-9. PubMed ID: 12363475
[TBL] [Abstract][Full Text] [Related]
7. Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.
Tönnies H; Huber S; Kuhl JS; Gerlach A; Ebell W; Neitzel H
Blood; 2003 May; 101(10):3872-4. PubMed ID: 12511406
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.
Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB;
Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873
[TBL] [Abstract][Full Text] [Related]
10. Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
Borges ML; Capela de Matos RR; Amaral BD; Soares-Ventura EM; Leite EP; Silva MO; Cornélio MT; Silva ML; Liehr T; Marques-Salles TD
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e85-e91. PubMed ID: 28212262
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
[TBL] [Abstract][Full Text] [Related]
12. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in Fanconi Anemia: The Importance of Follow-Up and the Search for New Biomarkers of Genomic Instability.
Merfort LW; Lisboa MO; Cavalli LR; Bonfim CMS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430597
[TBL] [Abstract][Full Text] [Related]
14. Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia.
Inoue A; Mori A; Yamazaki S; Suzuki R; Takitani K; Tamai H
Pediatr Int; 2018 Sep; 60(9):893-894. PubMed ID: 30255979
[No Abstract] [Full Text] [Related]
15. Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy.
Rochowski A; Rosenberg PS; Alonzo TA; Gerbing RB; Lange BJ; Alter BP
Leuk Res; 2012 Jan; 36(1):29-31. PubMed ID: 21974856
[TBL] [Abstract][Full Text] [Related]
16. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H
Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162
[TBL] [Abstract][Full Text] [Related]
17. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.
Auerbach AD; Allen RG
Cancer Genet Cytogenet; 1991 Jan; 51(1):1-12. PubMed ID: 1984836
[TBL] [Abstract][Full Text] [Related]
18. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
Korgaonkar S; Ghosh K; Vundinti BR
Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
[TBL] [Abstract][Full Text] [Related]
19. Azacitidine as a bridge to allogeneic hematopoietic cell transplantation in a pediatric patient with Fanconi anemia and acute myeloid leukemia.
Ding H; Hashem H; Cabral L; Rangarajan H; Abusin G; Lazarus HM; Abu-Arja R
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27976488
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
